References
- R.P.DellingerJ.M.CarletH.MasurSurviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCrit Care Med322004858873
- R.P.DellingerM.M.LevyJ.M.CarletInternational Surviving Sepsis Campaign Guidelines Committee Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shockCrit Care Med3612008296327 [Published correction appears inCrit Care Med. 2008;36(4):1394-1396]
- A.J.GarberE.S.MoghissiE.D.BransomeJrAmerican College of Endocrinology position statement on inpatient diabetes and metabolic controlEndocr Pract1020047782
- G.van den BergheP.WoutersF.WeekersIntensive insulin therapy in critically ill patientsN Engl J Med345200113591367
- P.DevosJ.C.PreiserC.MelotImpact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the Glucontrol studyIntensive Care Med33Suppl 22007S189
- F.M.BrunkhorstC.EngelF.BloosIntensive insulin therapy and pentastarch resuscitation in severe sepsisN Engl J Med3582008125139
- G.Van den BergheA.WilmerG.HermansIntensive insulin therapy in the medical ICUN Engl J Med3542006449461
- The NICE-SUGAR Study InvestigatorsIntensive versus conventional glucose control in critically ill patientsN Engl J Med360200912831297
- W.A.KnausE.A.DraperD.P.WagnerJ.E.ZimmermanAPACHE II: a severity of disease classification systemCritical Care Med13101985818829
- R.S.WienerD.C.WienerR.J.LarsonBenefits and risks of tight glucose control in critically ill adults: a meta-analysisJAMA3002008933944